Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Nkx-2.6 (NKX2-6) is a DNA-binding transcription factor belonging to the NK-2 homeobox family, and is a vertebrate homolog of Drosophila 'tinman.' It functions as a transcriptional activator and plays a crucial role, together with NKX2-5, in embryonic development of both the pharynx and the heart, particularly cardiac morphogenesis. Mutations in NKX2-6 have been associated with some forms of congenital heart defects, such as conotruncal heart malformations and persistent truncus arteriosus. However, it is not considered an established therapeutic drug target[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Nkx-2.6 (NKX2-6).